Keynote speakers

Austria

Dr. Lars Richter
University of Vienna
TIME IS RUNNING – LARGE SCALE MATCHED MOLECULAR PAIR ANALYSIS TO DOMESTICATE BINDING KINETICS.

Prof. Michael Schnürch
Institute of Applied Synthetic Chemistry, Vienna University of Technology
LEOLIGIN-INSPIRED SYNTHETIC LIGNANS WITH SELECTIVITY FOR CELL-TYPE AND BIOACTIVITY, RELEVANT FOR CARDIOVASCULAR DISEASE

Croatia

Dr. Ana Amić
Josip Juraj Strossmayer University of Osijek
ANTHRAQUINONES AS POTENTIAL FREE RADICAL SCAVENGERS AND P-GLYCOPROTEIN INHIBITORS

Assoc. Prof. Zrinka Rajić
Faculty of Pharmacy and Biochemistry, University of Zagreb
HARMICINES AS NOVEL ANTIPLASMODIAL LEADS

Czech Republic

Dr. Zlatko Janeba
Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences
DEVELOPMENT OF POLYSUBSTITUTED PYRIMIDINES AS POTENT INHIBITORS OF PROSTAGLANDIN E2 PRODUCTION

Dr. Jan Zitko
Faculty of Pharmacy in Hradec Králové, Charles University
STRUCTURAL MODIFICATIONS OF PYRAZINAMIDE – RATIONAL DESIGN TOWARDS NEW POTENTIAL ANTI-MICROBIAL COMPOUNDS

Greece

Dr. Theodora Calogeropoulou
Institute of Biology, Medicinal Chemistry and Biotechnology
National Hellenic Research Foundation
CONSTRAINED MILTEFOSINE DERIVATIVES. THE JOURNEY TOWARDS NMT-A2, A NEW DRUG LEAD FOR VISCERAL LEISHMANIASIS

Assoc. Prof. Angeliki Kourounakis
University of Athens
MORPHOLINE: A PRIVILEGED SCAFFOLD FOR THE DEVELOPMENT OF MULTI-TARGET BIOACTIVE MOLECULES

Hungary

Dr. Zsuzsa Baranyai
MTA-ELTE Research Group of Peptide Chemistry
SYNTHESIS AND IN VITRO BIOLOGICAL EVALUATION OF DRUG-PEPTIDE CONJUGATES AGAINST GLIOBLASTOMA

Prof. Tibor Kurtan
University Debrecen
BIOACTIVE BENZENE-CONDENSED HETEROCYCLES

Italy

Prof. Agostino Marrazzo
University of Catania
FROM HALOPERIDOL TO NEW SELECTIVE SIGMA RECEPTOR LIGANDS

Poland

Dr. Anna Wieckowska
Faculty of Pharmacy, Jagiellonian University Medical College
SEROTONIN 5-HT6 RECEPTOR ANTAGONISTS AND CHOLINESTERASE INHIBITORS WITH Aβ ANTIAGGREGATION PROPERTIES IN THE DEVELOPMENT OF MULTIFUNCTIONAL LIGANDS AGAINST ALZHEIMER’S DISEASE

Portugal

Dr. Jose Miguel Ferreira de Oliveira
LAQV, REQUIMTE, Laboratory of Applied Chemistry, Faculty of Pharmacy, University of Porto
REGULATION OF CYCLIN AND CYCLIN-DEPENDENT KINASE EXPRESSION BY 3’,4’-DIHYDROXYFLAVONOL IN HUMAN IN VITRO MODELS

Slovakia

Dr. Lucia Kováčiková
Institute of Experimental Pharmacology & Toxicology
Slovak Academy of Sciences
ISOSTERIC REPLACEMENT BROUGHT MARKEDLY IMPROVED SELECTIVITY OF ALDOSE REDUCTASE INHIBITORS

Dr. Magdaléna Májeková
Institute of Experimental Pharmacology & Toxicology
Slovak Academy of Sciences
TARGETING SERCA THROUGH DRUG DESIGN

Slovenia

Assoc. Prof. Martina Hrast
Faculty of Pharmacy, University of Ljubljana
COVALENT WARHEADS AS NEW MURA INHIBITORS

Assoc. Prof. Izidor Sosič
Faculty of Pharmacy, University of Ljubljana
DEVELOPMENT OF NON-PEPTIDIC AND SUBUNIT-SELECTIVE INHIBITORS OF IMMUNOPROTEASOME